中国实用医药
中國實用醫藥
중국실용의약
CHINA PRACTICAL MEDICAL
2015年
17期
41-42
,共2页
王士强%张琦辉%宋同均%刘裕浩%董世节
王士彊%張琦輝%宋同均%劉裕浩%董世節
왕사강%장기휘%송동균%류유호%동세절
依达拉奉%脑出血术后%神经功能缺损
依達拉奉%腦齣血術後%神經功能缺損
의체랍봉%뇌출혈술후%신경공능결손
Edaravone%After cerebral hemorrhage operation%Neurologic impairment
目的:观察依达拉奉注射液应用于脑出血术后患者的疗效。方法78例脑出血术后患者随机分为治疗组(39例)和对照组(39例)。对照组给予常规治疗,治疗组在常规治疗基础上加用依达拉奉注射液治疗。分别于治疗前及治疗后2、4周进行神经功能缺损评分(NIHSS),3个月后行日常生活能力评分(BI),并进行统计学分析。结果治疗组治疗2、4周NIHSS分别为(11.7±3.5)、(8.9±3.1)分;对照组NIHSS分别为(15.7±4.6)、(13.2±3.4)分,两组比较差异有统计学意义(P<0.01)。3个月后治疗组BI显效率为61.54%、有效率为84.62%;对照组BI显效率为38.46%、有效率为64.10%,两组比较差异有统计学意义(P<0.01)。结论依达拉奉能促进脑出血术后患者的神经功能康复,且安全有效。
目的:觀察依達拉奉註射液應用于腦齣血術後患者的療效。方法78例腦齣血術後患者隨機分為治療組(39例)和對照組(39例)。對照組給予常規治療,治療組在常規治療基礎上加用依達拉奉註射液治療。分彆于治療前及治療後2、4週進行神經功能缺損評分(NIHSS),3箇月後行日常生活能力評分(BI),併進行統計學分析。結果治療組治療2、4週NIHSS分彆為(11.7±3.5)、(8.9±3.1)分;對照組NIHSS分彆為(15.7±4.6)、(13.2±3.4)分,兩組比較差異有統計學意義(P<0.01)。3箇月後治療組BI顯效率為61.54%、有效率為84.62%;對照組BI顯效率為38.46%、有效率為64.10%,兩組比較差異有統計學意義(P<0.01)。結論依達拉奉能促進腦齣血術後患者的神經功能康複,且安全有效。
목적:관찰의체랍봉주사액응용우뇌출혈술후환자적료효。방법78례뇌출혈술후환자수궤분위치료조(39례)화대조조(39례)。대조조급여상규치료,치료조재상규치료기출상가용의체랍봉주사액치료。분별우치료전급치료후2、4주진행신경공능결손평분(NIHSS),3개월후행일상생활능력평분(BI),병진행통계학분석。결과치료조치료2、4주NIHSS분별위(11.7±3.5)、(8.9±3.1)분;대조조NIHSS분별위(15.7±4.6)、(13.2±3.4)분,량조비교차이유통계학의의(P<0.01)。3개월후치료조BI현효솔위61.54%、유효솔위84.62%;대조조BI현효솔위38.46%、유효솔위64.10%,량조비교차이유통계학의의(P<0.01)。결론의체랍봉능촉진뇌출혈술후환자적신경공능강복,차안전유효。
Objective To observe the curative effect of edaravone injection in the treatment of patients after cerebral hemorrhage operation.Methods A total of 78 patients after cerebral hemorrhage operation were randomly divided into treatment group (39 cases) and control group (39 cases). The control group received conventional treatment, and the treatment group received additional 30 mg of edaravone injection for treatment. National institutes of health stroke scale (NIHSS) was applied before treatment and in 2 and 4 weeks after treatment, and Barthel index (BI) was applied after 3 months. The scores were statistically analyzed.Results The treatment group had NIHSS scores in 2 and 4 weeks as respectively (11.7±3.5) and (8.9±3.1) points, and those of the control group were (15.7±4.6) and (13.2±3.4) points. The difference between the two groups had statistical significance (P<0.01). After 3 months, the excellent rate of BI was 61.54% in the treatment group, and its effective rate was 84.62%. The control group had excellent rate as 38.46% and effective rate as 64.10%. The difference between the two groups had statistical significance (P<0.01).Conclusion Edaravone can accelerate rehabilitation of neurological function after cerebral hemorrhage operation, with safety and effectiveness.